Psychedelics Then and Now with Zach Leary - Episode 42 - Dr. Robin Carhart-Harris

Episode 42 - Dr. Robin Carhart-Harris

05/26/21 • 58 min

Psychedelics Then and Now with Zach Leary

This all new episode of the MAPS Podcast features an interview with Dr. Robin Carhart-Harris, a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London.

Dr. Carhart-Harris takes us through the near exhaustive psychedelic research that he's personally overseen as well as sharing his thoughts on the future of psychedelics and their influence on science, therapy and our culture at large.

Robin Carhart-Harris is a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. He coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.

After being awarded an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, he relocated to Imperial College London to continue his fMRI research with the classic psychedelic psilocybin. In conjunction with David Nutt, he built up a program of psychedelic research that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA, and plans for an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.

The Multidisciplinary Association for Psychedelic Studies (MAPS) Podcast is hosted by Zach Leary and aims to bring you discussions with some of the leaders in the new age of psychedelic research and culture.

Episode 42 - Dr. Robin Carhart-Harris

Previous Episode

Episode 41 - Aubrey Marcus

The MAPS Podcast returns with a new episode featuring Aubrey Marcus, the founder and CEO of ONNIT.

Aubrey Marcus is the founder of Onnit, a lifestyle brand based on a holistic health philosophy he calls Total Human Optimization. Since its founding, Onnit has become an Inc. 500 company and industry leader with over 250 products ranging from peak performance supplements to foods, fitness equipment, and apparel.

Aubrey discusses the effects psychedelics have on our mystical state of awareness as well as our physical holistic selves. He is candid and visionary in his approach to how psychedelics have informed all aspects of his life and our culture at large.

Next Episode

Episode 43 - Dr. Tony Bossis

Meeting the End of Life with Psychedelics

In this all new episode of the MAPS Podcast, Zach Leary sits down with NYU's Dr. Tony Bossis to talk about a single dose of psilocybin can provide an entirely new perspective in dealing with death and dying. Dr. Bossis shares so much wisdom, knowledge and unique understanding on his work and the future of psychedelic research.

Anthony P. Bossis, PhD, is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine conducting FDA-approved research with the psychedelic compound psilocybin since 2009. Dr. Bossis was director of palliative care research and co-principal investigator on a clinical trial demonstrating a reduction in emotional distress from a single psilocybin session in persons with cancer and is study director on a clinical trial evaluating psilocybin-generated mystical experience upon religious leaders. Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital Center and co-founder and former co-director of the Bellevue Hospital Palliative Care Service. He has a long-standing interest in comparative religion, mystical experience and the interface of psychology and spirituality. He maintains a private psychotherapy and consulting practice in NYC.